| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |